UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000013006
Receipt No. R000015097
Scientific Title Phase I study of cetuximab plus U3-1565 in colorectal cancer with resistance to anti-EGFR antibody
Date of disclosure of the study information 2014/03/01
Last modified on 2020/02/03 10:29:38

No. Disposal Last modified on Item of update
1 Insert 2014/01/29 11:56:08
2 Update 2014/08/03 14:02:49 Recruitment status
Anticipated trial start date
3 Update 2014/08/03 14:03:19 Email1
4 Update 2015/01/29 14:04:10 Last name of lead principal investigator
Last name of lead principal investigator
Email
Last name of contact person
Last name of contact person
Email
5 Update 2020/02/03 10:13:15 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Address
Name of person sending information
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
6 Update 2020/02/03 10:17:29 Recruitment status
Date of IRB
Last follow-up date
7 Update 2020/02/03 10:27:57 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
8 Update 2020/02/03 10:29:38 Date of IRB
Last follow-up date


Contact us.